Experienced Customer Service Executive Joins EVault to Manage Support, Services and Operations

SAN FRANCISCO - Wednesday, May 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- EVault, Inc., a Seagate Company (NASDAQ: STX), today announced the appointment of Brett Flinchum as vice president of worldwide operations. Flinchum, a seasoned business leader with more than 15 years of operations experience, will lead EVault’s worldwide operations department, which is responsible for business services, IT operations, technical support, customer and expert services.

"Brett brings the perfect blend of experience and vision to oversee our worldwide operations and take it to the next level,” said Terry Cunningham, president and general manager of EVault. "Over the course of his career he has excelled in building and streamlining high-performing customer service and operations teams, skills that will help EVault continue to deliver world-class service to our tens of thousands of custom ... Read more »

NEW YORK--(BUSINESS WIRE)--The Board of Directors of JPMorgan Chase & Co. (NYSE:JPM) today declared a quarterly dividend of 38 cents per share on the outstanding shares of the corporation's common stock, an increase from the prior quarterly dividend of 30 cents per share. The dividend is payable on July 31, 2013, to stockholders of record at the close of business on July 5, 2013.

   At the annual meeting of shareholders held today, the Company announced preliminary results of the shareholder vote on five management proposals and four shareholder proposals. All of the management proposals were approved, including: the election of directors, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, approval of executive compensation, amendment to the Restated Certificate of Incorporation authorizing shareholder action by written consent, and reapproval of the Key Executive Performance Plan. None of the shareholder propos ... Read more »

Intelligent Energy’s consumer electronics division selected by telecom, Etisalat for user trial



LONDON - Wednesday, May 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Intelligent Energy, the global power technology company, today announced a collaboration with world-leading telecommunications company, Etisalat Nigeria, starting immediately. The companies will work together to test personal energy devices powered by Intelligent Energy’s proven fuel cell technology, with an Etisalat user trial to commence in this quarter.

With the growth in demand for mobile services and data, reliable and off-grid energy is becoming increasingly important. The scope of the Etisalat trial will include in-field testing of a new, cutting-edge solution, based on Intelligent Energy’s clean energy technology with selected customers across various devices.

"Etisalat believes in providing our customers with up to date solutions that will improve their mobile experience, and that ... Read more »

Biopharma Recognizes Quintiles as the Leader in Customer Loyalty Among Large Clinical Research Organizations (CROs) in Quality Benchmarking Report

RESEARCH TRIANGLE PARK, N.C. - Wednesday, May 22nd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Quintiles is the industry leader that best differentiates itself on service quality in Phase II/III clinical research, according to 157 pharmaceutical and biotechnology professionals who responded to Industry Standard Research’s (ISR) 2013 CRO Quality Benchmarking Report – Phase II/III. Respondents also rated Quintiles as the leader among large CROs for customer loyalty, defined by overall satisfaction, willingness to recommend and likelihood to use Quintiles again.

"We are deeply committed to helping our customers increase their probability of success at every stage of the product lifecycle,” said Paula Brown Stafford, President, Clinical Development at Quintiles. "We are delighted to see that our leadership and commitment to both q ... Read more »

PHILADELPHIA - Tuesday, May 21st 2013 [ME NewsWire]

    Tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least ICS/LABA therapy
    The improvements in lung function with tiotropium were specific to asthma patients; as a co-morbid condition, chronic obstructive pulmonary disease (COPD) was excluded in this trial

(BUSINESS WIRE)-- For Media outside the U.S., Canada and UK

In patients with symptomatic asthma despite at least ICS/LABA therapy, tiotropium delivered by the Respimat® SoftMistTM Inhaler increases time to first severe exacerbation and first episode of asthma worsening. This improvement is independent of age, allergic status, smoking status and bronchodilator response.1

This was the main finding from pre-planned subgroup analyses of data from the PrimoT ... Read more »